SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing intense volatility as traders react to conflicting signals involving renewed strikes in the Middle East and ongoing speculation regarding potential diplomatic breakthroughs. Community sentiment remains deeply divided between those betting on further supply shocks and higher prices due to geopolitical escalations, and those anticipating aggressive market interventions or potential ceasefires.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is experiencing renewed investor interest and technical strength, with shares pushing toward a key resistance level as sentiment shifts following the EU approval of its oral Wegovy pill. The community is actively debating the stock's long-term valuation relative to Eli Lilly and discussing the potential for a sustained breakout as the company expands its global reach and pipeline visibility.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors react to Temasek's recent stake disclosure and broader anticipation of a rebound heading into the next earnings report. The community is actively debating the company's long-term growth potential and store expansion against persistent concerns regarding its OTC status and historical volatility.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpool is facing significant market pressure ahead of earnings as investors debate whether the company is a deep-value turnaround play or a structural value trap hampered by heavy debt and weakening consumer demand. Community discussion is sharply divided between those calling for a board shakeup due to persistent underperformance and contrarian investors who are accumulating shares, citing the company's iconic status and historical oversold conditions.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors react to the company's aggressive repurchase of its convertible senior notes, signaling internal confidence ahead of anticipated commercial catalysts. The community is actively debating the timing of the YARTEMLEA J-code activation, upcoming CMS NTAP approval, and the potential for a near-term milestone payment from their Novo Nordisk partnership.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending due to the arrival of critical Siemens energy turbines at the Port of Houston, which serves as a major milestone for its Project Matador infrastructure, combined with aggressive community speculation regarding performance-based executive incentives tied to an imminent anchor tenant deal.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella Inc. (AMBA) is experiencing significant market movement following reports that NXP Semiconductors is in active discussions to acquire the AI chip designer, a move investors view as a strategic play to bolster NXPs automotive and edge AI capabilities. While the community is actively debating the likelihood of the deal and potential for competitive bids, traders are also focusing on the company's recent strong performance in the physical AI and robotics hardware sectors.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus Corporation is facing significant investor concern following a substantial dividend cut and earnings misses, leading to heavy selling pressure and volatility. The community is actively debating the company's long-term sustainability, management's strategic shift toward AI, and whether the current price represents an undervalued entry point or a deep-seated structural decline.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing heightened interest following a string of defense-related contract wins, including a significant production order that has bolstered investor confidence in its rugged edge computing hardware. The community remains focused on the potential for massive future deployments within U.S. Army situational awareness programs, viewing current market volatility as a consolidation phase before these long-term defense catalysts fully materialize.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is seeing intense volatility as the community remains divided over its transition to AI infrastructure, with investors closely watching for a long-awaited tenant announcement at its Corsicana facility. While bulls are highlighting increased power demand and analyst upgrades to defend the stock's potential, bears continue to express frustration over the company's underperformance compared to sector peers and ongoing uncertainty surrounding its long-term vision.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novo Nordisk is currently trending due to a combination of positive momentum from its recently approved oral Wegovy pill and an escalating legal conflict with Eli Lilly over marketing claims. The community remains largely bullish on the company's long-term cardiovascular and diabetes pipeline, viewing recent volatility as a buying opportunity rather than a shift in core fundamentals.

NVO Stock Slumps After Late-Stage Trial Fails Primary Goal – Retail Says ‘Current Revenue Drivers’ Still Intact

Novo Nordisk shares declined following the announcement that its Phase 3 ZEUS trial of the investigational drug ziltivekimab failed to meet its primary objective of reducing major adverse cardiovascular events. Despite this, the company confirmed that the trial results will not impact its 2026 adjusted operating profit outlook and that it will continue with other ongoing studies of the medication.

BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection?

Equity

BIOA clocked its worst day since December 2024 on Friday, while GLUE booked its worst day ever.


Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.

Key PointsBoth companies are giants in diabetes and obesity treatments...

Novo’s Phase 3 trial showed that investigational drug Ziltivekimab did not reduce major adverse cardiovascular events compared with the placebo


HIMS Stock Eyes 4-Week Losing Streak: Legal Woes Fuel ‘Very High’ Uncertainty As Analyst Sticks To ‘No Moat’ Call 

Morningstar maintained a ‘No Moat’ view, citing low telehealth barriers and offerings rivals can replicate “with relative ease.”

 VKTX Stock Lags GLP-1 Peers In July — But Viking CEO Says Its Obesity Drug Could Offer What Rivals Can’t 

Viking expects oral VK2735 Phase 3 studies to begin in Q4 and believes the pill could become the first oral dual GLP-1 agonist to reach the market.

How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q2 Results?

Novo Nordisk's Q2 results are set to spotlight Ozempic and Wegovy sales as oral launches and label expansions drive growth amid mounting competitive pressure.

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Investors claim Novo Nordisk misled the market about CagriSema's tolerability, after disappointing clinical trial results wiped billions off its market cap...

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Key PointsAmgen wants a slice of the weight loss drug market...

Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing

Novo Nordisk (NVO) reached $50.96 at the closing of the latest trading day, reflecting a +2.6% change compared to its last close.

Where Will Novo Nordisk Stock Be in 3 Years?

Key PointsNovo Nordisk remains a step behind Eli Lilly in the weight loss drug market...

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

The stock faced an aggressive sell-off following the disappointing ZEUS late-stage trial results for ziltivekimab, causing significant market cap volatility.

Many retail investors view the recent price decline as an irrational overreaction, emphasizing that the failed drug represented a small fraction of the firm's valuation.

Investors are shifting their attention to upcoming quarterly results, with high expectations that Wegovy pill success and strong guidance will drive a swift recovery.

Traders are buzzing with theories that the company should pivot to M&A or expand existing partnerships to strengthen its pipeline and regain investor confidence.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.77	--	--	N/A
Q1 '26	$0.91	$1.04	14.35%	BEAT
Q4 '25	$0.93	$0.95	2.82%	BEAT
Q3 '25	$0.75	$0.69	-7.91%	MISSED
Q2 '25	$0.92	$0.93	1.42%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings